COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,536 Articles (22,881 medRxiv, 8,655 bioRxiv)

Most recent first Previous |  Page 2466: Articles 24651-24660  | Next

Decreasing median age of COVID-19 cases in the United States: changing epidemiology or changing surveillance?
Greene, D. N., Jackson, M. L., Hillyard, D. R., Delgado, J. C., Schmidt, R. L.
10.1101/2020.07.22.20160119 — Posted: 2020-07-24
An analysis of mortality in Ontario using cremation data: Rise in cremations during the COVID-19 Pandemic
Postill, G., Murray, R., Wilton, A., Wells, R. A., Sirbu, R., Daley, M. J., Rosella, L. C.
10.1101/2020.07.22.20159913 — Posted: 2020-07-24
Using mobile phone data for epidemiological simulations of lockdowns: government interventions, behavioral changes, and resulting changes of reinfections
Müller, S. A., Balmer, M., Charlton, B., Ewert, R., Neumann, A., Rakow, C., Schlenther, T., Nagel, K.
10.1101/2020.07.22.20160093 — Posted: 2020-07-24
Circulating cytokines and lymphocyte subsets in patients who have recovered from COVID-19
None, H., Zhang, X., Li, X., Li, X., Li, D.
10.1101/2020.07.22.20160259 — Posted: 2020-07-24 Discussion: Onsite | Offsite
Remdesivir for COVID-19: match-population analysis with compassionate use of Remdesivir for severe COVID-19
Vasylyeva, O., Chen, T., Hanna, J.
10.1101/2020.07.22.20160002 — Posted: 2020-07-24
COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany
Rieg, S., von Cube, M., Kalbhenn, J., Utzolino, S., Pernice, K., Bechet, L., Baur, J., Lang, C. N., Wagner, D., Wolkewitz, M., Kern, W. V., Biever, P.
10.1101/2020.07.22.20160127 — Posted: 2020-07-24
Mathematical model study of a pandemic: Graded lockdown approach
Chateerjee, S., Vani, V. C., Banyal, R.
10.1101/2020.07.22.20159962 — Posted: 2020-07-24
What factors influence symptom reporting during an emerging infectious disease outbreak? A rapid review of the evidence
Carter, P., Megnin-Viggars, O., Rubin, G. J.
10.1101/2020.07.23.20159897 — Posted: 2020-07-24
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.
Weissman, D., Alameh, M.-G., LaBranche, C. C., Edwards, R. J., Sutherland, L., Santra, S., Mansouri, K., Gobeil, S., McDanal, C., Pardi, N., Shaw, P. A., Lewis, M. G., Boesler, C., Sahin, U., Acharya, P., Haynes, B. F., Korber, B., Montefiori, D. C.
10.1101/2020.07.22.20159905 — Posted: 2020-07-24 Discussion: Onsite | Offsite
Geographic reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase
Micheli, V., Rimoldi, S. G., Romeri, F., Comandatore, F., Mancon, A., Gigantiello, A., Brilli, M., Mileto, D., Pagani, C., Lombardi, A., Gismondo, M. R., Laboratory of Clinical Microbiology, Virology and Diagnostic of Bioemergencies Group
10.1101/2020.07.23.20159871 — Posted: 2020-07-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).